Stocks›Healthcare›NNOX

NNOX Nano-X Imaging LTD

NasdaqResearch view

Nano-X Imaging LTD operates in the X-Ray Apparatus & Tubes & Related Irradiation Apparatus industry.

$0.453−7.78%
Oct 16 close · 1D EOD · Databento
HealthcareX-Ray Apparatus & Tubes & Related Irradiation ApparatusMicro-capSEC EDGAR FY 2025-12-31

On the WireNo stories on NNOX yet. Follow the company and the next one lands in Following.

The numbers · FY2025, filed

SEC EDGAR
Market cap$32M
Revenue$13.0M+15.40%
Net income$-75.0M
EPS, diluted$-1.16−27.50%
Gross margin-98.2%
Operating margin-600.8%
All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31
SectorHealthcare
Market Cap$31.5M
Enterprise Value$-11.1M
Income$-75.0M
Sales$13.0M
Book/sh$2.01
Cash/sh$0.71
Dividend TTM—
Payout—
Employees—
IPO—
Quick Ratio3.77
Current Ratio3.96
Debt/Eq0.05
EPS (ttm)$-1.16
EPS this Y-27.5%
EPS past 3/5Y—
Sales past 3/5Y14.9%
EPS Y/Y TTM-27.5%
Sales Y/Y TTM15.4%
Shs Outstand69.59M
ROA-46.3%
ROE-53.7%
ROIC-82.4%
Gross Margin-98.2%
Oper. Margin-600.8%
Profit Margin-576.1%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$1.3M
FY21
$8.6M
FY22
$9.9M
FY23
$11.3M
FY24
$13.0M
FY25

Operating leverage — margins

GrossOperatingNet
0%40%80%-98%-601%-576%FY21FY22FY23FY24FY25
Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it
USDFY2021FY2022FY2023FY2024FY2025

Same industry

In the screener →

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.